Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks
Recruiting
N/A
Interventional Study
Mpox
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 5 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 650 (estimated)
- Sponsor
- University of Birmingham · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The MPXV CARE study principally aims to use clinical and epidemiology data to target specific individuals willing and able to provide appropriate and proportionate biological samples to develop novel immune diagnostics that support models of disease burden and future vaccine utilisation.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Healthy males and females aged between ages 5-80 years, who are able and willing to provide informed consent and will comply with the study requirements.
* Group 1 (suspected exposure cohort) only
* Live within or adjacent to an epidemiologically identified region of Mpox t…
Contacts